Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
Rotator cuff injury; This is a spontaneous report received from a Consumer or other non HCP. A female patient (not pregnant) received BNT162b2 (BNT162B2), in 2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 2021, for Covid-19 immunization, reaction(s): "First administration was administered too high in the shoulder", "Rotator cuff injury". The following information was reported: ROTATOR CUFF SYNDROME (disability, medically significant) with onset 2021, outcome "recovered with sequelae", described as "Rotator cuff injury". Therapeutic measures were taken as a result of rotator cuff syndrome. Clinical information: The reporter described an event in 2021 receiving the Covid vaccine. First administration was administered too high in the shoulder and caused a rotator cuff injury. This was reported to Pfizer. Second injection produced a similar injury. Surgery was required to resolve injury in the first case and may have been needed in the second case. Happened in 2021. The patient recovered with lasting effects. The event required surgical intervention. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202600037494 Same reporter, patient, and event, different dose;